Related references
Note: Only part of the references are listed.Silencing CD147 inhibits tumor progression and increases chemosensitivity in murine lymphoid neoplasm P388D1 cells
Li Jia et al.
ANNALS OF HEMATOLOGY (2009)
Inhibition of multi-drug resistance of ovarian carcinoma by small interfering RNA targeting to MRP2 gene
Jia-jia Ma et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2009)
Coexpression of invasive markers (uPA, CD44) and multiple drug-resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression
H. Chen et al.
BRITISH JOURNAL OF CANCER (2009)
A CD147-targeting siRNA inhibits the proliferation, invasiveness and VEGF production of human malignant melanoma cells by down-regulating glycolysis
Juan Su et al.
CANCER LETTERS (2009)
Hyaluronan, CD44, and Emmprin Regulate Lactate Efflux and Membrane Localization of Monocarboxylate Transporters in Human Breast Carcinoma Cells
Mark G. Slomiany et al.
CANCER RESEARCH (2009)
Anti-EMMPRIN Monoclonal Antibody as a Novel Agent for Therapy of Head and Neck Cancer
Nichole R. Dean et al.
CLINICAL CANCER RESEARCH (2009)
The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer
Celine Pinheiro et al.
EUROPEAN JOURNAL OF CANCER (2009)
CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models
W. Schneiderhan et al.
GUT (2009)
Increasing expression of monocarboxylate transporters 1 and 4 along progression to invasive cervical carcinoma
Celine Pinheiro et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2008)
Proteome Analysis of Multidrug Resistance of Human Oral Squamous Carcinoma Cells Using CD147 Silencing
Ye-Hong Kuang et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas
Celine Pinheiro et al.
VIRCHOWS ARCHIV (2008)
Drug resistance and the solid tumor microenvironment
Olivier Tredan et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Lung cancer - A comparative study of metabolism related protein expression in cancer cells and tumor associated stroma
Michael I. Koukourakis et al.
CANCER BIOLOGY & THERAPY (2007)
Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231
Shannon M. Gallagher et al.
CANCER RESEARCH (2007)
Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to paclitaxel in HO-8910pm cells
Wei Zou et al.
CANCER LETTERS (2007)
Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells
Danilo Millimaggi et al.
NEOPLASIA (2007)
HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma
Jing Xu et al.
MOLECULAR CANCER RESEARCH (2007)
Prognostic significance of extracellular matrix metalloproteinase inducer and matrix metalloproteinase 2 in epithelial ovarian cancer
S. Sillanpaa et al.
TUMOR BIOLOGY (2007)
ABCC2 (MRP2, cMOAT) can be localized in the nuclear membrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcome
Pawel Surowiak et al.
CLINICAL CANCER RESEARCH (2006)
The H+-linked monocarboxylate transporter (MCT1/SLC16A1):: A potential therapeutic target for high-risk neuroblastoma
Jun Fang et al.
MOLECULAR PHARMACOLOGY (2006)
Increasing expression of extracellular matrix metalloprotease inducer in ovary tumors: Tissue microarray analysis of immunostaining score with clinicopathological parameters
JS Jin et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2006)
HIV-1 Vpr induces DNA double-strand breaks
H Tachiwana et al.
CANCER RESEARCH (2006)
Mechanisms regulating tissue-specific polarity of monocarboxylate transporters and their chaperone CD147 in kidney and retinal epithelia
AA Deora et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Protection of platinum-DNA adduct formation and reversal of cisplatin resistance by anti-MRP2 hammerhead ribozymes in human cancer cells
V Materna et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2
S Misra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples
RT Penson et al.
GYNECOLOGIC ONCOLOGY (2004)
RNA expression of MDRI/P-glycoprotein, DNA-topoisomerase I, and MRP2 in ovarian carcinoma patients: correlation with chemotherapeutic response
V Materna et al.
GYNECOLOGIC ONCOLOGY (2004)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy
H Izumi et al.
CANCER TREATMENT REVIEWS (2003)
Drug resistance reversal - are we getting closer?
RD Baird et al.
EUROPEAN JOURNAL OF CANCER (2003)
The MRP family of drug efflux pumps
GD Kruh et al.
ONCOGENE (2003)
EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma
B Davidson et al.
CLINICAL & EXPERIMENTAL METASTASIS (2003)
Expression of monocarboxylate transporter MCTI in normal and neoplastic human CNS tissues
MK Froberg et al.
NEUROREPORT (2001)
CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression
P Kirk et al.
EMBO JOURNAL (2000)
Share Paper
